Jan 23 (Reuters) - Taiwan Leader Biotech Corp :
* Says it gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan
* LEAC-102 is used for adjunctive therapy of colorectal cancer
* The clinical trial will start up in May
Source text in Chinese: goo.gl/1t63QG
Further company coverage: (Beijing Headline News)
 